Search Results for keywords:"obesity treatment"

Found 2 results
Skip to main content

Search Results: keywords:"obesity treatment"

  • Type:Notice
    Citation:89 FR 95800
    Reading Time:about a minute or two

    The National Institutes of Health (NIH) has announced the availability of a government-owned invention for licensing, aimed at speeding up the commercialization of research funded by the government to benefit public health. This invention involves analogues of N-Lactoyl-Phenylalanine (Lac-Phe), which could serve as appetite suppressants and help treat obesity and related diseases. It is currently in the preclinical development stage and is open for licensing under U.S. patent law. Interested parties can contact Malabika Ghosh at the NIH for licensing details.

    Simple Explanation

    The government has a new medicine that might help people not feel hungry and could stop kids from getting too big; they want to share it with companies to make it useful for people soon.

  • Type:Notice
    Citation:86 FR 10592
    Reading Time:about 2 minutes

    The National Institute of Diabetes and Digestive and Kidney Diseases has scheduled several closed meetings to discuss grant applications. These meetings, set for April 1, 2, and 7, 2021, will be held via telephone conference and video meeting at the National Institutes of Health. The discussions will include sensitive information, such as confidential trade secrets and personal data, and are closed to the public to protect privacy. The meetings will review grant applications related to obesity treatment, neuronal cilia research, and gastrointestinal clinical studies.

    Simple Explanation

    The National Institute of Diabetes and Digestive and Kidney Diseases is having some private meetings to talk about who should get money to help study things like how to treat obesity, how certain parts of our body work, and how to study stomach problems. These meetings are not open to everyone because they need to talk about secret and personal stuff.